AKF staff participated in Kidney Care Partners (KCP) Capitol Hill advocacy day on June 13. KCP is a coalition of patient advocates, dialysis professionals, care providers and manufacturers dedicated to working together to improve quality of care for individuals with kidney disease. Working along fellow members of KCP, AKF staff met with congressional offices to lobby support for the Chronic Kidney Disease Improvement in Research and Treatment Act (H.R. 2644/S. 1890). This comprehensive kidney legislation would expand and enhance current research efforts related to chronic kidney disease, make technical fixes to the Medicare ESRD prospective payment system, make improvements to ESRD quality programs, and empower patient decision-making and choice by guaranteeing access to Medigap plans for all ESRD patients and allowing ESRD patients to enroll in Medicare Advantage plans starting in 2020, instead of 2021 as under current law.
Charitable premium assistance was also discussed in these meetings with congressional offices, as we asked members to co-sponsor H.R. 3976, the Access to Marketplace Insurance Act, and thanked others for their co-sponsorship. Currently, the bill has 171 co-sponsors.